Tag

Type 2 Diabetes

All articles tagged with #type 2 diabetes

health2 days ago•6 min saved

UK Sugar Rationing Ended in 1953, Creating a Natural Experiment on Long-Term Health

Recent studies using UK Biobank data suggest that the abrupt end of sugar rationing in 1953 created a natural experiment. Individuals exposed to low sugar levels during the first 1,000 days of life show significantly lower risks of type 2 diabetes, hypertension, and anxiety in adulthood. While the findings are observational, they indicate that early nutritional environments may have lasting physiological and psychological impacts.

via The Guardian|

#early-life-nutrition #health #mental-health

health-and-wellness3 days ago•7 min saved

Octavia Spencer Discovers Type 2 Diabetes During Routine Pre-Employment Physical in Her 30s

Oscar winner Octavia Spencer, 56, revealed to Prevention that she was diagnosed with type 2 diabetes in her 30s after a routine physical required for an acting role. The diagnosis prompted her to overhaul her lifestyle decades ago. No other outlets have reported on this specific disclosure.

via The Daily Beast|

#celebrity-health #health-and-wellness #health-diagnosis

health-and-science4 days ago•7 min saved

New Mouse Study Links Semaglutide to Slower Aging and Longer Lifespan

A new study in Nature demonstrates that semaglutide, a GLP-1 receptor agonist, slows aging and extends lifespan in female mice. While these drugs are approved for diabetes and obesity, emerging evidence suggests they offer broader therapeutic benefits beyond weight loss and glucose control, though the specific mechanisms remain unclear.

via Nature|

#aging-research #glp-1-agonists #health-and-science

health9 days ago•1 min saved

Lilly's amylin-tirzepatide combo outperforms retatrutide in diabetes weight loss trials

Eli Lilly reported that its experimental combination therapy, eloraTZP, achieved an average weight loss of 23.3% in patients with obesity and type 2 diabetes, surpassing its own triple-agonist candidate retatrutide in that specific population. The Phase 2 trial, presented at the European Association for the Study of Diabetes in Milan, showed that the highest dose of the amylin and tirzepatide combo resulted in a 54.1-pound loss over 48 weeks. While efficacy was strong, discontinuation rates due to gastrointestinal side effects were higher than for individual components. Lilly plans to begin Phase 3 trials in the fourth quarter of 2026, aiming to optimize dosing to improve tolerability while maintaining efficacy.

via Fierce Biotech|

#eli-lilly #eloratzp #health

health10 days ago•4 min saved

GLP-1 Switches Require Individualized Titration and Close Monitoring

Primary care providers are increasingly managing transitions between GLP-1 receptor agonists and dual incretin agents due to insurance changes, side effects, or efficacy issues. Experts emphasize that switching is not a simple swap; it requires careful planning around drug half-lives, individualized dose titration, and close monitoring for hypoglycemia. While these medications are highly effective, up to 15% of patients may see minimal results, and long-term success depends on combining medication with lifestyle changes.

via Medscape|

#clinical-guidelines #glp-1-receptor-agonists #health

health10 days ago•0 min saved

Eli Lilly’s Retatrutide Sets New Weight-Loss Records in Phase 3 Trials

Eli Lilly’s experimental triple-agonist drug retatrutide has demonstrated unprecedented weight-loss results in two major Phase 3 trials, with participants losing up to 25% of their body weight. The drug, which targets three gut hormones, also significantly improved blood sugar control and cardiometabolic markers, though it carries gastrointestinal side effects similar to existing GLP-1 medications.

via The Guardian|

#eli-lilly #glp-1 #health

health10 days ago•4 min saved

Eli Lilly’s Retatrutide Sets New Weight-Loss Records in Phase 3 Trials

Eli Lilly’s experimental triple-agonist retatrutide achieved record-breaking weight loss in two phase 3 trials, with participants losing up to 25% of body weight. The drug also improved cardiometabolic markers and resolved prediabetes in over 90% of cases, though it carries gastrointestinal side effects and lacks head-to-head comparisons with existing treatments.

via Ars Technica|

#eli-lilly #glp-1 #health

health11 days ago•396 min saved

Eli Lilly’s Retatrutide Sets New Weight Loss Records in Phase 3 Trials

Eli Lilly’s experimental triple-agonist drug, retatrutide, has demonstrated unprecedented weight loss in late-stage clinical trials. In a phase 3 study for patients with Type 2 diabetes, participants lost up to 23% of their body weight, while those with obesity but no diabetes lost up to 25%. The drug targets three hormones, including glucagon, to enhance metabolic effects beyond existing GLP-1 therapies. Lilly plans to file for FDA approval early next year, though unapproved versions are already circulating.

via NBC News|

#eli-lilly #glp-1-agonists #health

health12 days ago•18 min saved

Spinal Bone Density May Predict Cognitive Decline, New Study Finds

A new study published in Radiology indicates that lower bone density in the spine is associated with faster cognitive decline and changes in brain white matter. The research, led by Johns Hopkins University, used AI to analyze chest CT scans of 715 adults, finding that those with lower bone density experienced more rapid brain deterioration over five years. The link was particularly strong for individuals with type 2 diabetes. While the study does not prove causation, it suggests bone density could serve as an early marker for brain health risks.

via Everyday Health|

#dementia #health #johns-hopkins-university

health-and-entertainment13 days ago•2 min saved

Billy Gardell Credits 2021 Bariatric Surgery With Reversing Diabetes and Saving His Life

Billy Gardell revealed on the 'Breaking Bread' podcast that his 2021 bariatric surgery likely saved his life. The actor, who previously weighed up to 379 pounds, stated that the procedure eliminated his Type 2 diabetes and removed the need for medication. He attributes his decision to a knee injury that prevented exercise and doctor warnings about his heart and cholesterol. Gardell now maintains a weight between 210 and 215 pounds, citing his wife and son as primary motivators for the lifestyle change.

via New York Post|

#bariatric-surgery #billy-gardell #celebrity-health

health-and-science14 days ago•7 min saved

Harvard Data Links Modest Ice Cream Intake to Lower Diabetes Risk

A 2014 Harvard analysis of two long-term observational studies involving approximately 190,000 participants suggests that consuming small portions of ice cream weekly is associated with a lower statistical risk of type 2 diabetes and heart disease. While the findings highlight a potential link between dairy fat and metabolic health, researchers emphasize that the study is observational and cannot prove causation. Experts caution that these results do not justify unlimited consumption, noting that other dairy products like yogurt may offer more consistent health benefits, and that artificial stabilizers in some frozen desserts should be avoided.

via My Modern Met|

#dairy #harvard-study #health-and-science

health-and-science17 days ago•1 min saved

Roche’s Enicepatide Shows Superior Diabetes Control vs. Lilly’s Retatrutide in Phase 2 Trial

Roche reported that its dual GLP-1/GIP agonist enicepatide met primary endpoints in a phase 2 trial for type 2 diabetes, showing greater HbA1c reduction and weight loss than competitors at similar timepoints. The data supports Roche’s push to become a top-three obesity player despite analyst skepticism about Lilly’s dominance.

via Fierce Biotech|

#enicepatide #glp-1 #health-and-science

life-style18 days ago•15 min saved

Pritzker Credits GLP-1 for 80-Pound Weight Loss, Calls It Life-Changing

Illinois Governor JB Pritzker revealed that a GLP-1 medication, begun after a Type 2 diabetes diagnosis, has helped him shed about 80 pounds and he calls the change “life-changing.” He said doctors warned he might need insulin, but the GLP-1 has allowed him to avoid it, and he now walks four miles daily; he hopes sharing his experience will help others, despite Trump’s personal attacks on his weight.

via independent.co.uk|

#donald-trump #glp-1 #jb-pritzker

health23 days ago•10 min saved

Young-onset MASLD cirrhosis tied to genetics and diabetes, study finds

UC San Diego researchers define early-onset MASLD cirrhosis as cirrhosis before age 50, finding about 25% of MASLD-related cirrhosis cases fall in this group and are driven by a mix of inherited genetic risk and metabolic factors, notably type 2 diabetes; standard fibrosis tests that include age overlook roughly one-third of these patients, underscoring the need for earlier, more precise liver assessment to enable cancer surveillance as obesity and diabetes rise.

via News-Medical|

#cirrhosis #fatty-liver-disease #genetics

health1 month ago•5 min saved

Early Statin Start After Diabetes Diagnosis Linked to Lower Dementia Risk, Danish Registry Study Finds

A Danish registry study of 132,585 people with type 2 diabetes (2006–2019) found that starting statins within a year of diagnosis was linked to a 15% lower dementia risk over 10 years (3.3% vs. 3.9%), with later initiation still reducing risk (10% if started 1–5 years after). As observational data, it cannot prove causation, but findings support timely statin use for cardiovascular protection and potential dementia benefit in type 2 diabetes, pending medical guidance.

via ScienceAlert|

#dementia #denmark #health